Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 347

1.

Incidence of Knee Pain Beyond 1-Year: Suprapatellar versus Infrapatellar Approach for Intramedullary Nailing of the Tibia.

Isaac M, O'Toole RV, Udogwu U, Connelly D, Baker M, Lebrun CT, Manson TT, Zomar M, O'Hara N, Slobogean G.

J Orthop Trauma. 2019 May 8. doi: 10.1097/BOT.0000000000001504. [Epub ahead of print]

PMID:
31188254
2.

Immunization and multiple sclerosis: Recommendations from the French multiple sclerosis society.

Lebrun C, Vukusic S; French Group for Recommendations in Multiple Sclerosis (France4MS) and the Société Francophone de la Sclérose En Plaques (SFSEP).

Mult Scler Relat Disord. 2019 Jun;31:173-188. doi: 10.1016/j.msard.2019.04.004. Epub 2019 Apr 10. Review.

PMID:
31159998
3.

Immunization and multiple sclerosis: Recommendations from the French Multiple Sclerosis Society.

Lebrun C, Vukusic S; French Group for Recommendations in Multiple Sclerosis (France4MS), the Société francophone de la sclérose en plaques (SFSEP).

Rev Neurol (Paris). 2019 Jun;175(6):341-357. doi: 10.1016/j.neurol.2019.04.001. Epub 2019 Apr 27.

PMID:
31036391
4.

Model peptide for anti-sigma factor domain HHCC zinc fingers: high reactivity toward 1O2 leads to domain unfolding.

Chabert V, Lebrun V, Lebrun C, Latour JM, Sénèque O.

Chem Sci. 2019 Feb 21;10(12):3608-3615. doi: 10.1039/c9sc00341j. eCollection 2019 Mar 28.

5.

Oligoclonal bands increase the specificity of MRI criteria to predict multiple sclerosis in children with radiologically isolated syndrome.

Makhani N, Lebrun C, Siva A, Narula S, Wassmer E, Brassat D, Brenton JN, Cabre P, Carra Dallière C, de Seze J, Durand Dubief F, Inglese M, Langille M, Mathey G, Neuteboom RF, Pelletier J, Pohl D, Reich DS, Ignacio Rojas J, Shabanova V, Shapiro ED, Stone RT, Tenembaum S, Tintoré M, Uygunoglu U, Vargas W, Venkateswaren S, Vermersch P, Kantarci O, Okuda DT, Pelletier D; Observatoire Francophone de la Sclérose en Plaques (OFSEP), Société Francophone de la Sclérose en Plaques (SFSEP), the Radiologically Isolated Syndrome Consortium (RISC) and the Pediatric Radiologically Isolated Syndrome Consortium (PARIS).

Mult Scler J Exp Transl Clin. 2019 Mar 20;5(1):2055217319836664. doi: 10.1177/2055217319836664. eCollection 2019 Jan-Mar.

6.

Phosphate-Rich Biomimetic Peptides Shed Light on High-Affinity Hyperphosphorylated Uranyl Binding Sites in Phosphoproteins.

Laporte FA, Lebrun C, Vidaud C, Delangle P.

Chemistry. 2019 Jun 26;25(36):8570-8578. doi: 10.1002/chem.201900646. Epub 2019 May 30.

PMID:
30908736
7.

Disgust assessment: Factorial structure and psychometric properties of the French version of the Disgust Propension and Sensibility Scale Revised-12.

Novara C, Boiché J, Lebrun C, Macgregor A, Mateo Y, Raffard S.

PLoS One. 2019 Jan 28;14(1):e0210639. doi: 10.1371/journal.pone.0210639. eCollection 2019.

8.

Multiple sclerosis with atypical MRI presentation: Results of a nationwide multicenter study in 57 consecutive cases.

Codjia P, Ayrignac X, Carra-Dalliere C, Cohen M, Charif M, Lippi A, Collongues N, Corti L, De Seze J, Lebrun C, Vukusic S, Durand-Dubief F, Labauge P; SFSEP and OFSEP.

Mult Scler Relat Disord. 2019 Feb;28:109-116. doi: 10.1016/j.msard.2018.12.022. Epub 2018 Dec 18.

PMID:
30592992
9.

Assessing Sleep-Related Safety Behaviors: Adaptation and Validation of a French Version of the Sleep-Related Behaviors Questionnaire in a Nonclinical Sample.

Lebrun C, Gély-Nargeot MC, Maudarbocus KH, Bayard S.

Behav Sleep Med. 2018 Nov 21:1-13. doi: 10.1080/15402002.2018.1546178. [Epub ahead of print]

PMID:
30462561
10.

Digestive side-effects with teriflunomide: Thoughts on lactose.

Lebrun C, Bertagna M, Bresch S, Cohen M.

Rev Neurol (Paris). 2018 Dec;174(10):722-725. doi: 10.1016/j.neurol.2017.11.010. Epub 2018 Nov 5.

PMID:
30409479
11.

De novo convulsive status epilepticus in patients with multiple sclerosis treated with dalfampridine.

Panicucci E, Cohen M, Bourg V, Rocher F, Thomas P, Lebrun C.

Mult Scler. 2019 Apr;25(4):618-621. doi: 10.1177/1352458518790379. Epub 2018 Oct 30.

PMID:
30375922
12.

Concussion Burden, Recovery, and Risk Factors in Elite Youth Ice Hockey Players.

Schneider KJ, Nettel-Aguirre A, Palacios-Derflingher L, Mrazik M, Brooks BL, Woollings K, Blake T, McKay C, Lebrun C, Barlow K, Taylor K, Lemke N, Meeuwisse WH, Emery CA.

Clin J Sport Med. 2018 Oct 8. doi: 10.1097/JSM.0000000000000673. [Epub ahead of print]

PMID:
30300143
13.

ABCB1 (P-glycoprotein) regulates vitamin D absorption and contributes to its transintestinal efflux.

Margier M, Collet X, le May C, Desmarchelier C, André F, Lebrun C, Defoort C, Bluteau A, Borel P, Lespine A, Reboul E.

FASEB J. 2019 Feb;33(2):2084-2094. doi: 10.1096/fj.201800956R. Epub 2018 Sep 17.

PMID:
30222077
14.

Prediction of tibial nonunion at the 6-week time point.

Ross KA, O'Halloran K, Castillo RC, Coale M, Fowler J, Nascone JW, Sciadini MF, LeBrun CT, Manson TT, Carlini AR, Jolissaint JE, O'Toole RV.

Injury. 2018 Nov;49(11):2075-2082. doi: 10.1016/j.injury.2018.07.033. Epub 2018 Jul 29.

PMID:
30172349
15.

Cancer Risk in Patients with Multiple Sclerosis: Potential Impact of Disease-Modifying Drugs.

Lebrun C, Rocher F.

CNS Drugs. 2018 Oct;32(10):939-949. doi: 10.1007/s40263-018-0564-y. Review.

PMID:
30143945
16.

Inaugural tumor-like multiple sclerosis: clinical presentation and medium-term outcome in 87 patients.

Balloy G, Pelletier J, Suchet L, Lebrun C, Cohen M, Vermersch P, Zephir H, Duhin E, Gout O, Deschamps R, Le Page E, Edan G, Labauge P, Carra-Dallieres C, Rumbach L, Berger E, Lejeune P, Devos P, N'Kendjuo JB, Coustans M, Auffray-Calvier E, Daumas-Duport B, Michel L, Lefrere F, Laplaud DA, Brosset C, Derkinderen P, de Seze J, Wiertlewski S; Société Francophone de la Sclérose en Plaques.

J Neurol. 2018 Oct;265(10):2251-2259. doi: 10.1007/s00415-018-8984-7. Epub 2018 Jul 27.

PMID:
30054790
17.

Short oligopeptides with three cysteine residues as models of sulphur-rich Cu(i)- and Hg(ii)-binding sites in proteins.

Mesterházy E, Lebrun C, Crouzy S, Jancsó A, Delangle P.

Metallomics. 2018 Sep 19;10(9):1232-1244. doi: 10.1039/c8mt00113h.

PMID:
30043818
18.

Demyelinating diseases.

Lebrun C, de Seze J.

Rev Neurol (Paris). 2018 Jun;174(6):355. doi: 10.1016/j.neurol.2018.04.007. No abstract available.

PMID:
29903398
19.

Only Follow-Up of Memory B Cells Helps Monitor Rituximab Administration to Patients with Neuromyelitis Optica Spectrum Disorders.

Lebrun C, Cohen M, Rosenthal-Allieri MA, Bresch S, Benzaken S, Marignier R, Seitz-Polski B, Ticchioni M.

Neurol Ther. 2018 Dec;7(2):373-383. doi: 10.1007/s40120-018-0101-4. Epub 2018 Jun 7.

20.

Should we treat patients with radiologically isolated syndrome (RIS)? Comments.

Lebrun C.

Rev Neurol (Paris). 2018 Dec;174(10):696-698. doi: 10.1016/j.neurol.2018.02.085. Epub 2018 May 17. No abstract available.

PMID:
29779851
21.

IOC consensus statement on relative energy deficiency in sport (RED-S): 2018 update.

Mountjoy M, Sundgot-Borgen JK, Burke LM, Ackerman KE, Blauwet C, Constantini N, Lebrun C, Lundy B, Melin AK, Meyer NL, Sherman RT, Tenforde AS, Klungland Torstveit M, Budgett R.

Br J Sports Med. 2018 Jun;52(11):687-697. doi: 10.1136/bjsports-2018-099193. No abstract available.

PMID:
29773536
22.

International Olympic Committee (IOC) Consensus Statement on Relative Energy Deficiency in Sport (RED-S): 2018 Update.

Mountjoy M, Sundgot-Borgen J, Burke L, Ackerman KE, Blauwet C, Constantini N, Lebrun C, Lundy B, Melin A, Meyer N, Sherman R, Tenforde AS, Torstveit MK, Budgett R.

Int J Sport Nutr Exerc Metab. 2018 Jul 1;28(4):316-331. doi: 10.1123/ijsnem.2018-0136. Epub 2018 May 17. No abstract available.

PMID:
29771168
23.

The dialysis orders objective structured clinical examination (OSCE): a formative assessment for nephrology fellows.

Prince LK, Campbell RC, Gao SW, Kendrick J, Lebrun CJ, Little DJ, Mahoney DL, Maursetter LA, Nee R, Saddler M, Watson MA, Yuan CM; Nephrology Education Research & Development Consortium.

Clin Kidney J. 2018 Apr;11(2):149-155. doi: 10.1093/ckj/sfx082. Epub 2017 Aug 23.

24.

Rhythmic abilities and musical training in Parkinson's disease: do they help?

Cochen De Cock V, Dotov DG, Ihalainen P, Bégel V, Galtier F, Lebrun C, Picot MC, Driss V, Landragin N, Geny C, Bardy B, Dalla Bella S.

NPJ Parkinsons Dis. 2018 Mar 23;4:8. doi: 10.1038/s41531-018-0043-7. eCollection 2018.

25.

Structural model, functional modulation by ivermectin and tissue localization of Haemonchus contortus P-glycoprotein-13.

David M, Lebrun C, Duguet T, Talmont F, Beech R, Orlowski S, André F, Prichard RK, Lespine A.

Int J Parasitol Drugs Drug Resist. 2018 Apr;8(1):145-157. doi: 10.1016/j.ijpddr.2018.02.001. Epub 2018 Feb 15.

26.

Cerebrospinal fluid chitinase-3-like protein 1 level is not an independent predictive factor for the risk of clinical conversion in radiologically isolated syndrome.

Thouvenot E, Hinsinger G, Demattei C, Uygunoglu U, Castelnovo G, Pittion-Vouyovitch S, Okuda D, Kantarci O, Pelletier D, Lehmann S, Marin P, Siva A, Lebrun C.

Mult Scler. 2019 Apr;25(5):669-677. doi: 10.1177/1352458518767043. Epub 2018 Mar 22.

PMID:
29564952
27.

In-vivo patellar tracking in individuals with patellofemoral pain and healthy individuals.

Esfandiarpour F, Lebrun CM, Dhillon S, Boulanger P.

J Orthop Res. 2018 Feb 28. doi: 10.1002/jor.23887. [Epub ahead of print]

28.

Mercury Trithiolate Binding (HgS3) to a de Novo Designed Cyclic Decapeptide with Three Preoriented Cysteine Side Chains.

Sénèque O, Rousselot-Pailley P, Pujol A, Boturyn D, Crouzy S, Proux O, Manceau A, Lebrun C, Delangle P.

Inorg Chem. 2018 Mar 5;57(5):2705-2713. doi: 10.1021/acs.inorgchem.7b03103. Epub 2018 Feb 14.

PMID:
29443519
29.

A Constrained Tetrapeptide as a Model of Cu(I) Binding Sites Involving Cu4S6 Clusters in Proteins.

Mesterházy E, Lebrun C, Jancsó A, Delangle P.

Inorg Chem. 2018 May 21;57(10):5723-5731. doi: 10.1021/acs.inorgchem.7b02735. Epub 2018 Jan 12.

PMID:
29327922
30.

Psychological processes associated with insomnia in patients with multiple sclerosis.

Schellaert V, Labauge P, Lebrun C, Maudarbocus KH, Bernard J, Blache JB, Ayrignac X, Carra-Dallière C, Gely-Nargeot MC, Bayard S.

Sleep. 2018 Mar 1;41(3). doi: 10.1093/sleep/zsy002.

PMID:
29309702
31.

Characterization of epitope specificities of reference antibodies used for the quantification of the birch pollen allergen Bet v 1.

Brier S, Le Mignon M, Jain K, Lebrun C, Peurois F, Kellenberger C, Bordas-Le Floch V, Mascarell L, Nony E, Moingeon P.

Allergy. 2018 May;73(5):1032-1040. doi: 10.1111/all.13364. Epub 2017 Dec 12.

PMID:
29171882
32.

Anomalies Characteristic of Central Nervous System Demyelination: Radiologically Isolated Syndrome.

Lebrun C, Kantarci OH, Siva A, Pelletier D, Okuda DT; RISConsortium.

Neurol Clin. 2018 Feb;36(1):59-68. doi: 10.1016/j.ncl.2017.08.004. Review.

PMID:
29157404
33.

Treating asymptomatic bacteriuria before immunosuppressive therapy during multiple sclerosis: Should we do it?

Rouzaud C, Hautecoeur P, Donze C, Heinzlef O, Dinh A; Club Francophone de la Sclérose en Plaque, Creange A, Abdullatif A, Audouin B, Tourbah A, Berger E, Bourre B, Brochet B, Mekies C, Cabre P, Papeix C, Casez O, Brassat D, Defer G, Derache N, De Seze J, Dive D, LePage E, Fromont A, Gouider R, Edan G, Pelletier J, Grimaud J, Guennoc AM, Camdessanché JP, Kwiatkowski A, Laplaud D, Lebrun C, Debouverie M, Coustans M, Gout O, La Rochelle OA, Heinzlef O, Ouallet JC, Cavelou P, Hautecoeur P, Labauge P, Vermersch P, Wiertlewski S, Vukusic S, Marignier R, Schluep M, Seeldrayers P, Slassi I, Stankoff B, Thaite F, Moreau T, Thouvenot E, Zephir H, Ciron J, Collongues N, Kerschen P, Cohen M, Gueguen A, Mathey G, Carra C, Bernady P, Faucheux JM, Planque E, Donze C, Ruet A, Mouzawakh C, Pittion S.

Mult Scler Relat Disord. 2017 Nov;18:161-163. doi: 10.1016/j.msard.2017.08.009. Epub 2017 Aug 24. No abstract available.

PMID:
29141801
34.

Cognition and quality of life in clinically isolated syndrome patients starting a disease modifying therapy in the QUALICIS study may not predict treatment response at one year.

Cohen M, Brochet B, Clavelou P, Le Page E, Vermersch P, Tourbah A, Moreau T, Joly H, Sakarovitch C, Lebrun C; Qualicis Study Group.

J Neurol Sci. 2017 Nov 15;382:73-78. doi: 10.1016/j.jns.2017.09.030. Epub 2017 Sep 22.

PMID:
29111024
35.

Growth Mechanism and Surface State of CuInS2 Nanocrystals Synthesized with Dodecanethiol.

Gromova M, Lefrançois A, Vaure L, Agnese F, Aldakov D, Maurice A, Djurado D, Lebrun C, de Geyer A, Schülli TU, Pouget S, Reiss P.

J Am Chem Soc. 2017 Nov 8;139(44):15748-15759. doi: 10.1021/jacs.7b07401. Epub 2017 Oct 19.

PMID:
28994294
36.

Radiologically isolated syndrome in children: Clinical and radiologic outcomes.

Makhani N, Lebrun C, Siva A, Brassat D, Carra Dallière C, de Seze J, Du W, Durand Dubief F, Kantarci O, Langille M, Narula S, Pelletier J, Rojas JI, Shapiro ED, Stone RT, Tintoré M, Uygunoglu U, Vermersch P, Wassmer E, Okuda DT, Pelletier D.

Neurol Neuroimmunol Neuroinflamm. 2017 Sep 25;4(6):e395. doi: 10.1212/NXI.0000000000000395. eCollection 2017 Nov.

37.

Radiologically isolated syndrome should be treated with disease-modifying therapy - Commentary.

Lebrun C.

Mult Scler. 2017 Dec;23(14):1821-1823. doi: 10.1177/1352458517727149. Epub 2017 Sep 14. No abstract available.

PMID:
28906166
38.

A Trishistidine Pseudopeptide with Ability to Remove Both CuΙ and CuΙΙ from the Amyloid-β Peptide and to Stop the Associated ROS Formation.

Conte-Daban A, Boff B, Candido Matias A, Aparicio CNM, Gateau C, Lebrun C, Cerchiaro G, Kieffer I, Sayen S, Guillon E, Delangle P, Hureau C.

Chemistry. 2017 Dec 1;23(67):17078-17088. doi: 10.1002/chem.201703429. Epub 2017 Nov 9.

39.

A Case Report of Solitary Sclerosis: This is Really Multiple Sclerosis.

Lebrun C, Cohen M, Mondot L, Ayrignac X, Labauge P.

Neurol Ther. 2017 Dec;6(2):259-263. doi: 10.1007/s40120-017-0082-8. Epub 2017 Aug 24.

40.

Incidence of Vacuum Phenomenon Related Intra-articular or Subfascial Gas Found on Computer-Assisted Tomography (CT) Scans of Closed Lower Extremity Fractures.

Noble T, Romeo NM, LeBrun CT, DiPasquale T.

J Orthop Trauma. 2017 Nov;31(11):e381-e384. doi: 10.1097/BOT.0000000000000962.

PMID:
28827506
41.

Functional Outcomes of Elderly Patients With Nonoperatively Treated Acetabular Fractures That Meet Operative Criteria.

Ryan SP, Manson TT, Sciadini MF, Nascone JW, LeBrun CT, Castillo RC, Muppavarapu R, Schurko B, OʼToole RV.

J Orthop Trauma. 2017 Dec;31(12):644-649. doi: 10.1097/BOT.0000000000000990.

PMID:
28742787
42.

Natalizumab-PML survivors with subsequent MS treatment: Clinico-radiologic outcome.

Maillart E, Vidal JS, Brassat D, Stankoff B, Fromont A, de Sèze J, Taithe F, Clavelou P, Bourre B, Delvaux V, Rico A, Labauge P, Tourbah A, Lebrun C, Pelletier J, Moreau T, Louapre C, Lubetzki C, Papeix C.

Neurol Neuroimmunol Neuroinflamm. 2017 Apr 14;4(3):e346. doi: 10.1212/NXI.0000000000000346. eCollection 2017 May.

43.

Validation of a French version of the Sleep Condition Indicator: a clinical screening tool for insomnia disorder according to DSM-5 criteria.

Bayard S, Lebrun C, Maudarbocus KH, Schellaert V, Joffre A, Ferrante E, Le Louedec M, Cournoulat A, Gely-Nargeot MC, Luik AI.

J Sleep Res. 2017 Dec;26(6):702-708. doi: 10.1111/jsr.12556. Epub 2017 May 26.

44.

Redox Self-Adaptation of a Nitrene Transfer Catalyst to the Substrate Needs.

Gouré E, Senthilnathan D, Coin G, Albrieux F, Avenier F, Dubourdeaux P, Lebrun C, Maldivi P, Latour JM.

Angew Chem Int Ed Engl. 2017 Apr 3;56(15):4305-4309. doi: 10.1002/anie.201612472. Epub 2017 Mar 15.

PMID:
28295906
45.

Cyclic Phosphopeptides to Rationalize the Role of Phosphoamino Acids in Uranyl Binding to Biological Targets.

Starck M, Laporte FA, Oros S, Sisommay N, Gathu V, Solari PL, Creff G, Roques J, Den Auwer C, Lebrun C, Delangle P.

Chemistry. 2017 Apr 19;23(22):5281-5290. doi: 10.1002/chem.201605481. Epub 2017 Mar 29.

PMID:
28164389
46.

Monitoring CD27+ memory B-cells in neuromyelitis optica spectrum disorders patients treated with rituximab: Results from a bicentric study.

Cohen M, Romero G, Bas J, Ticchioni M, Rosenthal M, Lacroix R, Brunet C, Rico A, Pelletier J, Audoin B, Lebrun C.

J Neurol Sci. 2017 Feb 15;373:335-338. doi: 10.1016/j.jns.2017.01.025. Epub 2017 Jan 10.

PMID:
28131216
47.

Double-Blind Controlled Randomized Trial of Cyclophosphamide versus Methylprednisolone in Secondary Progressive Multiple Sclerosis.

Brochet B, Deloire MS, Perez P, Loock T, Baschet L, Debouverie M, Pittion S, Ouallet JC, Clavelou P, de Sèze J, Collongues N, Vermersch P, Zéphir H, Castelnovo G, Labauge P, Lebrun C, Cohen M, Ruet A; PROMESS study investigators.

PLoS One. 2017 Jan 3;12(1):e0168834. doi: 10.1371/journal.pone.0168834. eCollection 2017.

48.

[Internal fixation of the distal radius: Medical liability considerations].

Lebrun C.

Hand Surg Rehabil. 2016 Dec;35S:S162-S165. doi: 10.1016/j.hansur.2016.04.003. Epub 2016 Oct 24. Review. French.

PMID:
27890205
49.

What Is New in Trauma-Related Amputations.

Tintle SM, LeBrun C, Ficke JR, Potter BK.

J Orthop Trauma. 2016 Oct;30 Suppl 3:S16-S20.

PMID:
27661421
50.

Therapeutic target of memory B cells depletion helps to tailor administration frequency of rituximab in myasthenia gravis.

Lebrun C, Bourg V, Bresch S, Cohen M, Rosenthal-Allieri MA, Desnuelle C, Ticchioni M.

J Neuroimmunol. 2016 Sep 15;298:79-81. doi: 10.1016/j.jneuroim.2016.07.009. Epub 2016 Jul 11.

PMID:
27609279

Supplemental Content

Loading ...
Support Center